WallStSmart
IPHA

Innate Pharma

NASDAQ: IPHA · HEALTHCARE · BIOTECHNOLOGY

$1.48
+5.71% today

Updated 2026-04-29

Market cap
$138.87M
P/E ratio
P/S ratio
15.42x
EPS (TTM)
$-0.64
Dividend yield
52W range
$1 – $3
Volume
0.0M

Innate Pharma (IPHA) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$360000.00$-9.28M$-14.74M$-5.94M$-13.45M$12.99M$-10.47M$-10.97M$-18.13M$207.91M$-36.85M$-48.06M$-32.53M$34.92M$-51.81M$-58.46M$-19.15M$-32.56M$-6.90M$-50.67M
Capital expenditures$752000.00$1.30M$1.90M$511000.00$408000.00$322000.00$1.23M$433000.00$2.34M$7.40M$9.39M$6.03M$1.43M$65.40M$11.28M$1.33M$1.12M$2.35M$391000.00$134474.00
Depreciation$298000.00$536000.00$539000.00$1.02M$1.10M$901000.00$839000.00$880000.00$2.34M$2.65M$3.26M$4.39M$7.40M$16.53M$56.80M$4.60M$45.41M$5.09M$1.99M
Stock-based comp$1.19M$1.26M$1.34M$1.77M$35000.00$219000.00$325000.00$377000.00$1.01M$1.03M$9.83M$2.71M$3.83M$2.48M$2.62M$4.25M$4.26M$3.94M$4.26M
Free cash flow$-392000.00$-10.58M$-16.64M$-6.45M$-13.86M$12.66M$-11.70M$-11.40M$-20.48M$200.51M$-46.24M$-54.09M$-33.96M$-30.48M$-63.09M$-59.79M$-20.28M$-34.91M$-7.29M$-50.81M
Investing cash flow$-38.99M$4.97M$22.52M$18.94M$-289000.00$2.44M$-3.41M$-958000.00$-3.82M$-122.30M$60.51M$-29.46M$24.28M$-62.12M$-13.37M$-917000.00$1.88M$20.63M$9.20M
Financing cash flow$42.21M$631000.00$623000.00$22.56M$-893000.00$-659000.00$-2.15M$19.68M$47.95M$3.03M$-602000.00$915000.00$61.22M$77.77M$-1.14M$26.82M$-1.83M$-1.97M$-6.01M
Dividends paid$1.20M$850000.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Share repurchases
Debt repayment
Net change in cash$0.00$0.00$0.00$0.00$0.00